1. Home
  2. AORT vs PLSE Comparison

AORT vs PLSE Comparison

Compare AORT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AORT
  • PLSE
  • Stock Information
  • Founded
  • AORT 1984
  • PLSE 2014
  • Country
  • AORT United States
  • PLSE United States
  • Employees
  • AORT N/A
  • PLSE N/A
  • Industry
  • AORT Medical/Dental Instruments
  • PLSE Medical/Dental Instruments
  • Sector
  • AORT Health Care
  • PLSE Health Care
  • Exchange
  • AORT Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • AORT 1.4B
  • PLSE 1.1B
  • IPO Year
  • AORT 1993
  • PLSE 2016
  • Fundamental
  • Price
  • AORT $31.66
  • PLSE $16.03
  • Analyst Decision
  • AORT Strong Buy
  • PLSE Buy
  • Analyst Count
  • AORT 5
  • PLSE 1
  • Target Price
  • AORT $32.40
  • PLSE $22.00
  • AVG Volume (30 Days)
  • AORT 349.3K
  • PLSE 197.4K
  • Earning Date
  • AORT 08-07-2025
  • PLSE 08-11-2025
  • Dividend Yield
  • AORT N/A
  • PLSE N/A
  • EPS Growth
  • AORT N/A
  • PLSE N/A
  • EPS
  • AORT N/A
  • PLSE N/A
  • Revenue
  • AORT $390,084,000.00
  • PLSE N/A
  • Revenue This Year
  • AORT $12.18
  • PLSE N/A
  • Revenue Next Year
  • AORT $10.39
  • PLSE N/A
  • P/E Ratio
  • AORT N/A
  • PLSE N/A
  • Revenue Growth
  • AORT 5.94
  • PLSE N/A
  • 52 Week Low
  • AORT $21.97
  • PLSE $13.50
  • 52 Week High
  • AORT $32.94
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • AORT 62.03
  • PLSE 50.73
  • Support Level
  • AORT $30.06
  • PLSE $15.19
  • Resistance Level
  • AORT $32.94
  • PLSE $17.27
  • Average True Range (ATR)
  • AORT 0.79
  • PLSE 0.78
  • MACD
  • AORT 0.06
  • PLSE 0.20
  • Stochastic Oscillator
  • AORT 61.37
  • PLSE 52.76

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: